MYDA Advisors’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-30,000
Closed -$536K 144
2024
Q1
$536K Buy
+30,000
New +$536K 0.15% 73